Results 321 to 330 of about 14,739,736 (367)
Advanced Functional Materials, EarlyView.Develop full‐color colloidal perovskite nanocrystal (PNC) composites using a single organic halide precursor and enhance their stability and emission through zirconium hydrogen phosphate nanosheets (NSs). Achieve high photoluminescence efficiency and dual‐state circularly polarized luminescence (CPL) by embedding stabilized PNCs into a chiral polymer ...
Deblina Das +6 more
wiley +1 more source
Advanced Functional Materials, EarlyView.It is demonstrated that severe lattice distortion and coherent nanoprecipitates overcome the strength–ductility dilemma and mitigate discontinuous plastic flow (DPF) at 4.2 K. Such microstructural design enhances both thermal and athermal stress components, leading to exceptional mechanical performance.
Min Young Sung +11 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Function of extravascular coagulation factor IX in haemostasis
Haemophilia, 2021The majority of clotting factor IX (FIX) resides extravascularly, in the subendothelial basement membrane, where it is important for haemostasis.
D. Mann +4 more
semanticscholar +1 more source
Blood Coagulation & Fibrinolysis, 1992
Within the past 20 years or so, factor IX has been at the centre of particularly intensive studies of its physiology, pathology and biochemistry as well as its molecular genetics and biology. With the complete nucleotide sequence of its human gene determined in 1985 and the molecular defects of over 600 abnormal human factor IX genes analysed to date ...
K, Kurachi +3 more
openaire +3 more sources
Within the past 20 years or so, factor IX has been at the centre of particularly intensive studies of its physiology, pathology and biochemistry as well as its molecular genetics and biology. With the complete nucleotide sequence of its human gene determined in 1985 and the molecular defects of over 600 abnormal human factor IX genes analysed to date ...
K, Kurachi +3 more
openaire +3 more sources
Heterogeneity of factor IX in therapeutic factor IX concentrates
Thrombosis Research, 1978Abstract Rabbit antibody to human factor IX was used to investigate the factor IX antigenic content and electrophoretic mobility of commercial products as well as experimental “activated products”. Rocket immunoelectrophoresis of all concentrates showed a 1.2–3 fold increased antigenic content/unit factor IX clotting activity when compared to plasma.
D, Menache, D L, Aronson
openaire +2 more sources
Thrombosis and Haemostasis, 1997
Despite the introduction of recombinant preparations of factor VIII and recombinant factor VII and VIIa, patients with other forms of hemophilia, especially hemophilia B, have remained at increased risk for blood borne viruses because of a lack of clinically utilizable preparations of recombinant factor IX.
G C, White, A, Beebe, B, Nielsen
openaire +2 more sources
Despite the introduction of recombinant preparations of factor VIII and recombinant factor VII and VIIa, patients with other forms of hemophilia, especially hemophilia B, have remained at increased risk for blood borne viruses because of a lack of clinically utilizable preparations of recombinant factor IX.
G C, White, A, Beebe, B, Nielsen
openaire +2 more sources
Thrombosis Research, 1986
Abnormal factor IX was isolated from the plasma of a patient with hemophilia B Kashihara and two patients with hemophilia BM. The F.IX was purified to homogeneity by using monoclonal anti-F.IX-Sephrose, heparin-Sepharose and DEAE-Sephadex A-50 affinity chromatography successively.
A, Yoshioka +7 more
openaire +2 more sources
Abnormal factor IX was isolated from the plasma of a patient with hemophilia B Kashihara and two patients with hemophilia BM. The F.IX was purified to homogeneity by using monoclonal anti-F.IX-Sephrose, heparin-Sepharose and DEAE-Sephadex A-50 affinity chromatography successively.
A, Yoshioka +7 more
openaire +2 more sources